投融资数据库
免费查数据
注册送3天会员
首页>投融资
千金湘药
收并购
Hunan Qianjin Xiangjiang Pharmaceutical Co Ltd, former Zhuzhou Xiangjiang Pharmaceutical Factory, was founded in 1971. It is a subsidiary of Zhuzhou Qianjin Pharmaceutical Co Ltd. It focuses on manufacture and sales of APIs and solid formulations including anti-infective, cardiovascular, digestive, endocrine system and special drugs.In May 2013, China Hunan Technology & Science Department authorized Hunan Qianjin Xiangjiang Pharmaceutical to setup Hunan Engineering Research Center for antiviral drugs
基本信息
-
公司全称湖南千金湘江药业股份有限公司
-
类型化学药研发、生产、销售商
-
产业领域医药研发/制造、化学&生物药
-
公司人数500人以上
-
地址湖南省株洲市荷塘区金龙东路1号
-
联系电话0731-22131536
-
邮箱qjxjyy@vip.163.com
-
成立时间1998-05-25
相关投融资企业
E~PreIPO
Arthrosi Therapeutics LLC focuses on the treatment of uric acid levels and reduce joint damage for people living with gout.In July 2023, Arthrosi Therapeutics secured of $75 million in Series D financing
E~PreIPO
Arthrosi Therapeutics LLC focuses on the treatment of uric acid levels and reduce joint damage for people living with gout.In July 2023, Arthrosi Therapeutics secured of $75 million in Series D financing
收并购
Kronos Bio, Inc.于2017年6月2日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，致力于发现和开发新的癌症疗法，旨在通过针对失调转录的精确药物策略来改变患者的预后。
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息